I Am Taking a GLP-1 Weight-Loss Medication—What Should I Know?
JAMA Internal Medicine · 01.09.2025 · 185 (9) · 1180
DOI: 10.1001/jamainternmed.2025.1133 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Internal Medicine, erschienen am 01.09.2025. Verfasst von Farhad Mehrtash und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Die Arbeit wurde bisher 22-mal zitiert (Crossref).
Abstract (Originalsprache)
This JAMA Internal Medicine Patient Page describes how glucagon-like peptide-1 (GLP-1) receptor agonists work and what behaviors to adopt while using them.
Autor:innen und Institutionen
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
- Division of Endocrinology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
- Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Zitieren
APA
Mehrtash, F., Dushay, J., & Manson, J. E. (2025). I Am Taking a GLP-1 Weight-Loss Medication—What Should I Know?. JAMA Internal Medicine, 185(9), 1180. https://doi.org/10.1001/jamainternmed.2025.1133
Vancouver
Mehrtash F, Dushay J, Manson JE. I Am Taking a GLP-1 Weight-Loss Medication—What Should I Know?. JAMA Internal Medicine. 2025;185(9):1180. doi:10.1001/jamainternmed.2025.1133
BibTeX
@article{Mehrtash2025,
author = {Mehrtash, Farhad and Dushay, Jody and Manson, JoAnn E},
title = {I Am Taking a GLP-1 Weight-Loss Medication—What Should I Know?},
journal = {JAMA Internal Medicine},
year = {2025},
volume = {185},
number = {9},
pages = {1180},
doi = {10.1001/jamainternmed.2025.1133}
}
EUVIMED